-transparent.png){kind=logo}
The fraction of cells in S + G2 + mitosis from 54 urothelial tumours was calculated by flow cytometry after acridine orange (AO) staining of cells obtained by bladder irrigation or biopsy. Fluorescence signals emitted by the AO-stained DNA and RNA of each cell were separated optically and measured for 5,000 cells per specimen. The patients were classified by the histology of their tumours and clinical data into 5 diagnostic categories: NED (no evidence of disease, but history of bladder tumour), 3; papilloma, 8; non-invasive papillary carcinoma, 8; carcinoma in situ, 17 and invasive carcinoma, 18. The fraction of cells with DNA values in S + G2 + M of the cell cycle varied between 7 and 57% of the total, with a wide range within each diagnostic category, but no statistically significant differences between the groups. The proportion of cells in S + G2 + M from an individual tumour was not correlated with histologic grade or clinical behaviour. The possibility that some tumour cells with DNA values above G1 level are quiescent cells arrested at S or G2 is discussed.
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
November 1996,
Journal of clinical pathology,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
March 2023,
Scientific reports,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
January 1988,
Experimental gerontology,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
December 1977,
Cancer research,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
January 1986,
Archiv fur Geschwulstforschung,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
December 2005,
Biotechnology and bioengineering,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
January 1979,
Methods in enzymology,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
February 2011,
PloS one,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
January 1984,
Medical oncology and tumor pharmacotherapy,
L G Collste, and
Z Darzynkiewicz, and
F Traganos, and
T K Sharpless, and
M Devonec, and
M L Claps, and
W F Whitmore, and
M R Melamed
May 1982,
Cytometry,
